Cistron Biotechnology(CIST)$.30 | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cistron Biotechnology(CIST)$.30

An SI Board Since October 1996

Posts	SubjectMarks	Bans	Symbol
2742	9	0	CIST

Emcee: harry zelatis	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
242	The same thing has happened a number of times to me when trading a stock that h	Derek Greenamoyer	-	12/18/1996
241	That happened occasionally to me, too. So, are you going to lower your bid?	icecreambug	-	12/18/1996
240	CIST was down to .30 at the close today. Who is buying it at that low price?	Stephen McCullough	-	12/18/1996
239	BOB THE WINDSOR NEWSLETTER GAVE NO INDICATION AS TO WHEN IT WOULD "POP&qu	Seb Agapite	-	12/15/1996
238	It was the CEO that went without pay, but, thanks for the clear commentary. CI	scaram(o)uche	-	12/15/1996
237	Bob; Please don't give much credence to the reverse split theory. I, a no	Zvi Yammer	-	12/14/1996
236	All: I assume CIST managers are as busy as elves preparing a public announcment	John Chylek	-	12/14/1996
235	Richard, please open an account at National Discount Brokers. For any stock on	Andrew	-	12/12/1996
234	Wish I did have info on the Australia Biotech project. I'm trying to poke	scaram(o)uche	-	12/12/1996
233	Bob, 1) Don't know anything about AMDD, so can't comment 2) You're	Laertes Manuelidis	-	12/11/1996
232	Hi Laertes, I have seen quite a few posts saying the same about E*Trade and	Sidney Reilly	-	12/11/1996
231	Bob, Your reference to brokers and their charges is familiar to me. I have bee	Laertes Manuelidis	-	12/11/1996
230	Richard, The info you posted on Xenova's PAI inhibitor intrigues me. Right	Laertes Manuelidis	-	12/11/1996
229	Hi Richard, A 1 for 3 reverse split to take it to 3 would be very profitabl	Sidney Reilly	-	12/11/1996
228	hi mike, I looked at the windsor site but did not subscribe. I'm going o	Sidney Reilly	-	12/11/1996
227	My opinion........ once the frigging company finally gives insight with respec	scaram(o)uche	-	12/11/1996
226	That was the Windsor report on Cistron. The are quessing on the reverse split.	mike mulhearn	-	12/11/1996
225	Hi Laertes, In your post 213 you said, "A reverse split of the stock	Sidney Reilly	-	12/11/1996
224	This is the original demo that the IL-1beta-derived insert had adjuvant activit	scaram(o)uche	-	12/11/1996
223	This abstract isn't all that relevant. It describes an older study that fo	scaram(o)uche	-	12/10/1996
222	This abstract merely describes that the IL-1 beta sequence (residues 163-171) c	scaram(o)uche	-	12/10/1996
221	Gary..... I presume that a ton of people who bought with me on the day of the	scaram(o)uche	-	12/10/1996
220	Gary...read Post 213. At around .40 a share, this stock is apparently sitting	John Chylek	-	12/10/1996
219	Here's the abstract........ The Journal of Immunology: Volume: 157 Number:	scaram(o)uche	-	12/10/1996
218	Here's the Dow Jones article describing the Vical license from Stanford. I	scaram(o)uche	-	12/10/1996

Go to reply# or date (mm/dd/yy):